(Q48819086)

English

A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.

scientific article published in January 1983

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

phase II clinical trial

0 references

author name string

L G Feun

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

D J Stewart

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

M E Leavens

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

M A Burgess

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

N Savaraj

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

R S Benjamin

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

G P Bodey

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

publication date

1 January 1983

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

45-48

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

https://scigraph.springernature.com/pub.10.1007/bf00153640

0 references

Therapy of advanced gastrointestinal cancer with 1-3-bis-(2-chlorethyl)-l-nitrosourea (BCNU)

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy: the agents in current use

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-agent chemotherapy of brain tumors. A five-year review

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system leukemia and solid tumors of childhood. Treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU).

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00153640

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48819086&oldid=1386780866"